Top Posts

UN Convention against Cybercrime opens for signature in...

Maestra Amal Guermazi Leads “Mazzika” Orchestra in a...

Real Estate and Citizenship by Investment Expo –...

Nicolas Clinics Hosts “Wellness Week” in Dbayeh, Celebrating...

Landmark Rise in Student Participation Marks AUB’s 2025–26...

UN Lebanon Marks 80 Years of Partnership with...

146 UAE Nationals graduate from PureHealth’s Emirati Development...

Music Nation Starts Formal Operations, Launching New Era...

Airbus, Leonardo and Thales sign Memorandum of Understanding...

LAU Mobile Clinic at the Heart of Community...

Finance
Business
Tourism & Hospitality
Lifestyle & Health
Science & Technology
Humanitarian
Culture and Arts
News
PR Agency

Home Tags Posts tagged with "Orforglipron"

Tag:

Orforglipron

Lifestyle & Health slider
Lilly’s oral GLP-1, orforglipron, is successful in third Phase 3 trial, triggering global regulatory submissions this year for the treatment of obesity

by Karine Ayoub September 3, 2025

by Karine Ayoub September 3, 2025

In ATTAIN-2, orforglipron met the primary and all key secondary endpoints, with compelling efficacy results …

0 Facebook Twitter Pinterest Email

Weekly Notification

Bulletin’s Archive

Bulletin’s Archive

Search Bulletins

Tags

Abu Dhabi Ports American University of Beirut American University of Sharjah (AUS) AUB aubmc Bank Audi Blom Bank Breitling Byblos Bank cannes lions Corona Virus (COVID-19) COVID-19 Corona Elie Saab Emirates Ericsson Garena Free Fire Global Village Globemed Grohe Huawei Hyundai Kandima Maldives Kia Kia Corporation LAU Medical Center Rizk Hospital LG LG Electronics Maserati Mastercard NISSAN PRCA MENA Ralph & Russo Ramadan Rebirth Beirut Salesforce Samsung SAP Starzplay Tony Ward UN unesco UNICEF United Nations VFS Global Zuhair Murad

THE BULLETIN

All press releases and company news, brochures, logos, videos, images, and brands are property of their respective owners and not the bulletin.
All press releases and company news, brochures, logos, videos, images, and brands references used in this website are for identification and informational purposes only.
Use of these press releases and company news, brochures, logos, videos, images, and brands does not imply endorsement by, sponsorship by, or affiliation with the bulletin.

JOIN US

About us
Contact us
HOME

Keep in touch

Facebook

@2024 - All Right Reserved.

Finance
Business
Tourism & Hospitality
Lifestyle & Health
Science & Technology
Humanitarian
Culture and Arts
News
PR Agency